Literature DB >> 8698635

Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. II. Physico-chemical properties and structures.

C B Cui1, H Kakeya, H Osada.   

Abstract

Two novel diketopiperazines named tryprostatins A and B and a new natural product belonging to the diketopiperazine series, designated as demethoxyfumitremorgin C, together with four known diketopiperazines, fumitremorgin C, 12,13-dihydroxyfumitremorgin C, fumitremorgin B and verruculogen, are new M phase inhibitors of the mammalian cell cycle, which were isolated from the secondary metabolites of Aspergillus fumigatus. The structures of tryprostatins A, B and demethoxyfumitremorgin C were determined mainly by the use of spectroscopic methods especially by detailed analyses of their 1H and 13C NMR spectra with the aid of 2D NMR techniques including pulse field gradient heteronuclear multiple-bond correlation (PFG-HMBC) spectroscopy. Their absolute configurations were determined on the basis of the optical rotational values and CD spectra.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698635     DOI: 10.7164/antibiotics.49.534

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  17 in total

1.  Terminating Catalytic Asymmetric Heck Cyclizations by Stereoselective Intramolecular Capture of η-Allylpalladium Intermediates: Total Synthesis of (-)-Spirotryprostatin B and Three Stereoisomers.

Authors:  Larry E Overman; Mark D Rosen
Journal:  Tetrahedron       Date:  2010-08-14       Impact factor: 2.457

2.  Biochemical characterization of a novel indole prenyltransferase from Streptomyces sp. SN-593.

Authors:  Shunji Takahashi; Hiroshi Takagi; Atsushi Toyoda; Masakazu Uramoto; Toshihiko Nogawa; Masashi Ueki; Yoshiyuki Sakaki; Hiroyuki Osada
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

Review 3.  Oxidative Cyclization in Natural Product Biosynthesis.

Authors:  Man-Cheng Tang; Yi Zou; Kenji Watanabe; Christopher T Walsh; Yi Tang
Journal:  Chem Rev       Date:  2016-12-12       Impact factor: 60.622

4.  Isolation and insecticidal activity of mellamide from Aspergillus melleus.

Authors:  J G Ondeyka; A W Dombrowski; J P Polishook; T Felcetto; W L Shoop; Z Guan; S B Singh
Journal:  J Ind Microbiol Biotechnol       Date:  2003-04-08       Impact factor: 3.346

5.  Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions.

Authors:  Uwe Muenster; Birgit Grieshop; Karsten Ickenroth; Mark Jean Gnoth
Journal:  Pharm Res       Date:  2008-06-04       Impact factor: 4.200

6.  Engineered Production of Tryprostatins in E. coli through Reconstitution of a Partial ftm Biosynthetic Gene Cluster from Aspergillus sp.

Authors:  Gopitkumar R Shah; Shane R Wesener; Yi-Qiang Cheng
Journal:  Jacobs J Biotechnol Bioeng       Date:  2014-12-18

7.  Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein.

Authors:  Hiteshkumar D Jain; Chunchun Zhang; Shuo Zhou; Hao Zhou; Jun Ma; Xiaoxiang Liu; Xuebin Liao; Amy M Deveau; Christine M Dieckhaus; Michael A Johnson; Kirsten S Smith; Timothy L Macdonald; Hideaki Kakeya; Hiroyuki Osada; James M Cook
Journal:  Bioorg Med Chem       Date:  2008-02-20       Impact factor: 3.641

8.  Tryprostatin A, a specific and novel inhibitor of microtubule assembly.

Authors:  T Usui; M Kondoh; C B Cui; T Mayumi; H Osada
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 9.  Marine natural products as breast cancer resistance protein inhibitors.

Authors:  Lilia Cherigo; Dioxelis Lopez; Sergio Martinez-Luis
Journal:  Mar Drugs       Date:  2015-04-03       Impact factor: 5.118

10.  Prenylated indolediketopiperazine peroxides and related homologues from the marine sediment-derived fungus Penicillium brefeldianum SD-273.

Authors:  Chun-Yan An; Xiao-Ming Li; Chun-Shun Li; Gang-Ming Xu; Bin-Gui Wang
Journal:  Mar Drugs       Date:  2014-01-27       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.